Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 48 (2), 167-172
- https://doi.org/10.1016/s0026-0495(99)90028-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretionJournal of Clinical Endocrinology & Metabolism, 1995
- Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese womenJournal of Clinical Endocrinology & Metabolism, 1995
- Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variablesClinical Endocrinology, 1994
- Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and womenJournal of Clinical Endocrinology & Metabolism, 1994
- Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndromeJournal of Clinical Endocrinology & Metabolism, 1993
- The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*Clinical Endocrinology, 1993
- DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASESClinical Endocrinology, 1990
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Pathogenesis and Treatment of Polycystic Ovary SyndromeNew England Journal of Medicine, 1988